Page 51 - Sách năm 2022 - Fulltext - hieu final
P. 51

Cardiovasc Surg 2012;53:313-23.
                  17. Etezadi V, Benenati JF, Patel PJ, Patel RS, Powell A, Katzen BT. The reentry catheter: a second

                  chance for endoluminal reentry at difficult lower extremity subintimal arterial recanalizations. J Vasc
                  Intervent Radiol 2010;21:730-4.
                  18. Shin SH, Baril D, Chaer R, Rhee R, Makaroun M, Marone L. Limitations of the Outback LTD re-entry

                  device in femoropopliteal chronic total occlusions. J Vasc Surg 2011;53:1260-4.
                  19. Liang HL, Li MF, Chiang CL, Chen MC, Wu CJ, Pan HB. The use of

                  a Colapinto TIPS Needle under cone-beam computed tomography guidance for true lumen re-entry in
                  subintimal recanalization of chronic iliac artery occlusion. J Chin Med Assoc 2017;80:371-5.
                  20. Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment

                  of extensive aortoiliac occlusive disease. J Vasc Surg 2010;52:1376-83.
                  21. Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous
                  treatment of TransAtlantic InterSociety Consensus class C and D aorto-iliac lesions. J Vasc Surg

                  2011;53:1728-37.
                  22. Nanto K, Iida O, Fujihara M, Yokoi Y, Tomoi Y, Soga Y, et al.Five-year patency and its predictors
                  after endovascular therapy for aortoiliac occlusive disease. J Atherosclerosis Thromb 2019;26:989-96.

                  23. Marrocco-Trischitta MM, Bertoglio L, Tshomba Y, Kahlberg A, Marone EM, Chiesa R. The best
                  treatment of juxtarenal aortic occlusion is and will be open surgery. J Cardiovasc Surg 2012; 53:307-12.

                  24. Kretschmann T, Usai MV, Taneva GT, Pitoulias GA, Torsello G, Donas KP. The role of open and
                  endovascular treatment of patients with chronic aortoiliac Leriche syndrome. Vascular 2020;28:68-73.
                  25. Mwipatayi BP, Sharma S, Daneshmand A, Thomas SD, Vijayan V, Altaf N, et al. Durability of the

                  balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent
                  Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg 2016;64:83-94-1.

                  26. Taeymans K, Groot Jebbink E, Holewijn S, Martens JM, Versluis M, Goverde PCJM, et al. Three-year
                  outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac
                  occlusive disease. J Vasc Surg 018;67:1438-47.

                  27. Pejkic S, Dragaš M, Ilic N, et al. Incidence and relevance of groin incisional complications following
                  aortobifemoral bypass grafting. Ann Vasc Surg. 2014; 28(8):1832–9. [PubMed: 25011088]
                  28. Burke CR, Henke PK, Hernandez R, et al. A contemporary comparison of aortofemoral bypass and

                  aortoiliac stenting in the treatment of aortoiliac occlusive disease. Ann Vasc Surg. 2010; 24(1):4–13.
                  [PubMed: 20122461]
                  29. Bandyk DF, Novotney ML, Back MR, et al. Expanded application of in situ replacement for prosthetic

                  graft infection. J Vasc Surg. 2001; 4(3):411–19. discussion 419-420. [PubMed:11533591]


                                                                                                             51
   46   47   48   49   50   51   52   53   54   55   56